Virtual Medicinal Product (VMP) - Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices

Name Details

Name Start Date End Date
Name Current Name Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices Start Date 05-02-2019 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
3
UDFS UOM
ml
Unit Dose UOM
pre-filled disposable injection

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous
Form
Solution for injection
Ontology Form/Route
solutioninjection.subcutaneous
Non-availability Indicator
Actual Products Available
Name Basis
Other

Codes

ATC Code
A10AE54
BNF Codes
  • BNF code 06010102
SNOMED Codes
Code Start Date End Date
36630511000001105 05-02-2019

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Insulin glargine Based on Ingredient Substance 100 unit 1 ml
Lixisenatide Based on Ingredient Substance 33 microgram 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
3 pre-filled disposable injection 4860 Part VIIIA Category C